These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Anomalous observations on IPV and OPV vaccination. John TJ Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328 [TBL] [Abstract][Full Text] [Related]
25. Age and long-term protective immunity in dogs and cats. Schultz RD; Thiel B; Mukhtar E; Sharp P; Larson LJ J Comp Pathol; 2010 Jan; 142 Suppl 1():S102-8. PubMed ID: 19959181 [TBL] [Abstract][Full Text] [Related]
26. Dissecting the indirect effects caused by vaccines into the basic elements. Scarbrough Lefebvre CD; Terlinden A; Standaert B Hum Vaccin Immunother; 2015; 11(9):2142-57. PubMed ID: 26186100 [TBL] [Abstract][Full Text] [Related]
27. Immunosenescence and vaccine failure in the elderly: strategies for improving response. Boraschi D; Italiani P Immunol Lett; 2014 Nov; 162(1 Pt B):346-53. PubMed ID: 24960535 [TBL] [Abstract][Full Text] [Related]
28. [Vaccination--value for money?]. Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Kristiansen IS Tidsskr Nor Laegeforen; 2006 Oct; 126(20):2670-3. PubMed ID: 17057767 [TBL] [Abstract][Full Text] [Related]
29. New approaches to the assessment of vaccine herd protection in clinical trials. Clemens J; Shin S; Ali M Lancet Infect Dis; 2011 Jun; 11(6):482-7. PubMed ID: 21616458 [TBL] [Abstract][Full Text] [Related]
30. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity. Armstrong GL; Billah K; Rein DB; Hicks KA; Wirth KE; Bell BP Pediatrics; 2007 Jan; 119(1):e22-9. PubMed ID: 17200247 [TBL] [Abstract][Full Text] [Related]
31. [The concept of herd immunity applied to the evaluation of vaccination programs]. Zieliński A Przegl Epidemiol; 1999; 53(3-4):245-55. PubMed ID: 10800562 [TBL] [Abstract][Full Text] [Related]
33. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States. Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE; Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206 [TBL] [Abstract][Full Text] [Related]
34. Role of herd immunity in determining the effect of vaccines against sexually transmitted disease. Garnett GP J Infect Dis; 2005 Feb; 191 Suppl 1():S97-106. PubMed ID: 15627236 [TBL] [Abstract][Full Text] [Related]
36. Hepatitis A and B vaccination and public health. Hollinger FB; Bell B; Levy-Bruhl D; Shouval D; Wiersma S; Van Damme P J Viral Hepat; 2007 Nov; 14 Suppl 1():1-5. PubMed ID: 17958635 [TBL] [Abstract][Full Text] [Related]
37. [Adverse effects of the herd immunity or when childhood vaccination becomes deleterious for the epidemiology of infectious diseases in adults]. Lang PO Geriatr Psychol Neuropsychiatr Vieil; 2011 Mar; 9(1):11-9. PubMed ID: 21586372 [TBL] [Abstract][Full Text] [Related]
38. Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation model. De Wals P; Black S; Borrow R; Pearce D Clin Ther; 2009 Oct; 31(10):2152-69. PubMed ID: 19922887 [TBL] [Abstract][Full Text] [Related]
39. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs. Patel MM; Parashar UD J Infect Dis; 2009 Nov; 200 Suppl 1():S291-9. PubMed ID: 19817612 [TBL] [Abstract][Full Text] [Related]
40. Protecting the Community Through Child Vaccination. Anderson EJ; Daugherty MA; Pickering LK; Orenstein WA; Yogev R Clin Infect Dis; 2018 Jul; 67(3):464-471. PubMed ID: 29471452 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]